Patent details
EP3482768 Title: METHODS AND KITS FOR PREVENTING INFUSION REACTION RISK AND ANTIBODY-MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPY
Basic Information
- Publication number:
- EP3482768
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP182143933
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- METHODS AND KITS FOR PREVENTING INFUSION REACTION RISK AND ANTIBODY-MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPY
- French Title of Invention:
- PROCÉDÉS ET KITS POUR PRÉVENIR LE RISQUE DE RÉACTION DE PERFUSION ET PERTE INDUITE PAR ANTICORPS DE LA RÉPONSE PAR SURVEILLANCE DE L'ACIDE URIQUE SÉRIQUE PENDANT UNE THÉRAPIE URICASE PÉGYLÉE
- German Title of Invention:
- VERFAHREN UND KITS ZUR VERHINDERUNG DES INFUSIONSREAKTIONSRISIKOS UND VON ANTIKÖRPERVERMITTELTEM ANTWORTVERLUST DURCH ÜBERWACHUNG DER SERUM-HARNSÄURE WÄHREND DER PEGYLIERTEN URICASE-THERAPIE
- SPC Number:
Dates
- Filing date:
- 25/06/2010
- Grant date:
- 28/01/2026
- EP Publication Date:
- 15/05/2019
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 28/01/2026
- EP B1 Publication Date:
- 28/01/2026
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 25/06/2030
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 21/01/2026
- Name:
- Horizon Therapeutics USA, Inc.
- Address:
- 1 Horizon Way, Deerfield, Illinois 60015, United States (US)
Agent
- Name:
- ARONOVA S.A.
- From:
- 19/03/2026
- Address:
- PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
- To:
Inventor
1
- Name:
- WRIGHT, David, Erick
- Address:
- United States (US)
2
- Name:
- ROSARIO-JANSEN, Theresa
- Address:
- United States (US)
Priority
1
- Priority Number:
- 26966909 P
- Priority Date:
- 25/06/2009
- Priority Country:
- United States (US)
2
- Priority Number:
- 24869809 P
- Priority Date:
- 05/10/2009
- Priority Country:
- United States (US)
3
- Priority Number:
- 29871810 P
- Priority Date:
- 27/01/2010
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 38/44; G01N 33/53; G01N 33/68; A61K 9/00; A61P 19/02;
Publication
European Patent Bulletin
- Issue number:
- 202605
- Publication date:
- 28/01/2026
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 30/06/2026
- Annual Fee Number:
- 17
- Annual Fee Amount:
- 246 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 19/03/2026 | Power Of Attorney | 1 |
| 20/03/2026 | Outgoing Correspondence | 1 |